메뉴 건너뛰기




Volumn 16, Issue 9 II, 2003, Pages

Optimizing antihypertensive treatment in clinical practice

Author keywords

Antihypertensive therapy; Diabetes; Hypertension; Ischemic heart disease; blockers

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; METOPROLOL; PROPRANOLOL; THIAZIDE DIURETIC AGENT; TIMOLOL;

EID: 0141840826     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(03)00967-1     Document Type: Conference Paper
Times cited : (13)

References (25)
  • 2
    • 0037181148 scopus 로고    scopus 로고
    • Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study
    • Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D: Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002;287:1003-1010.
    • (2002) JAMA , vol.287 , pp. 1003-1010
    • Vasan, R.S.1    Beiser, A.2    Seshadri, S.3    Larson, M.G.4    Kannel, W.B.5    D'Agostino, R.B.6    Levy, D.7
  • 3
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S, for the HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-1762.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlöf, B.4    Elmfeldt, D.5    Julius, S.6    Menard, J.7    Rahn, K.H.8    Wedel, H.9    Westerling, S.10
  • 6
    • 0031838873 scopus 로고    scopus 로고
    • Prevalence, treatment, and control of hypertension in the French population: Data from a survey on high blood pressure in general practice, 1994
    • Chamontin B, Poggi L, Lang T, Menard J, Chevalier H, Gallois H, Cremier O: Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994. Am J Hypertens 1998;11:759-762.
    • (1998) Am J Hypertens , vol.11 , pp. 759-762
    • Chamontin, B.1    Poggi, L.2    Lang, T.3    Menard, J.4    Chevalier, H.5    Gallois, H.6    Cremier, O.7
  • 7
    • 0031836866 scopus 로고    scopus 로고
    • Blood pressure screening, management and control in England: Results from the health survey for England 1994
    • Colhoun HM, Dong W, Poulter NR: Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998;16:747-752.
    • (1998) J Hypertens , vol.16 , pp. 747-752
    • Colhoun, H.M.1    Dong, W.2    Poulter, N.R.3
  • 8
    • 0030946960 scopus 로고    scopus 로고
    • Hypertension awareness, treatment and control in the community: Is the 'rule of halves' still valid?
    • Marques-Vidal P, Tuomilehto J: Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid? J Hum Hypertens 1997;11:213-220.
    • (1997) J Hum Hypertens , vol.11 , pp. 213-220
    • Marques-Vidal, P.1    Tuomilehto, J.2
  • 9
    • 0034927743 scopus 로고    scopus 로고
    • Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994)
    • Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001;161:1207-1216.
    • (2001) Arch Intern Med , vol.161 , pp. 1207-1216
    • Coresh, J.1    Wei, G.L.2    McQuillan, G.3    Brancati, F.L.4    Levey, A.S.5    Jones, C.6    Klag, M.J.7
  • 10
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting anzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting anzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
    • (2002) JAMA , vol.288 , pp. 2981-2997
  • 12
    • 0035899874 scopus 로고    scopus 로고
    • Guidelines for the management of patients with chronic stable angina: Treatment
    • Fihn SD, Williams SV, Daley J, Gibbons RJ, for the American College of Cardiology; the American Heart Association; the American College of Physicians-American Society of Internal Medicine: Guidelines for the management of patients with chronic stable angina: treatment. Ann Intern Med 2001;135:616-632.
    • (2001) Ann Intern Med , vol.135 , pp. 616-632
    • Fihn, S.D.1    Williams, S.V.2    Daley, J.3    Gibbons, R.J.4
  • 14
    • 0019459311 scopus 로고
    • Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
    • Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-807.
    • (1981) N Engl J Med , vol.304 , pp. 801-807
  • 15
    • 0019519095 scopus 로고
    • The Beta-Blocker Heart Attack Trial
    • Beta-Blocker Heart Attack Study Group: The Beta-Blocker Heart Attack Trial. JAMA 1981;246:2073-2074.
    • (1981) JAMA , vol.246 , pp. 2073-2074
  • 16
    • 0035810547 scopus 로고    scopus 로고
    • Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: The CAPRICORN randomised trial
    • Dargie HJ, for the CAPRICORN Investigators: Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385-1390.
    • (2001) Lancet , vol.357 , pp. 1385-1390
    • Dargie, H.J.1
  • 17
    • 0033229973 scopus 로고    scopus 로고
    • Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project
    • Chen J, Marciniak TA, Radford MJ, Wang Y, Krumholz HM: Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project. J Am Coll Cardiol 1999;34:1388-1394.
    • (1999) J Am Coll Cardiol , vol.34 , pp. 1388-1394
    • Chen, J.1    Marciniak, T.A.2    Radford, M.J.3    Wang, Y.4    Krumholz, H.M.5
  • 18
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS II)
    • CIBIS II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS II). Lancet 1999;353:9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
  • 19
    • 0037159310 scopus 로고    scopus 로고
    • Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study
    • Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, DeMets DL, for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group: Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study. Circulation 2002;106:2194-2199.
    • (2002) Circulation , vol.106 , pp. 2194-2199
    • Packer, M.1    Fowler, M.B.2    Roecker, E.B.3    Coats, A.J.4    Katus, H.A.5    Krum, H.6    Mohacsi, P.7    Rouleau, J.L.8    Tendera, M.9    Staiger, C.10    Holcslaw, T.L.11    Amann-Zalan, I.12    DeMets, D.L.13
  • 20
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
    • MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-2007.
    • (1999) Lancet , vol.353 , pp. 2001-2007
  • 21
    • 0032511601 scopus 로고    scopus 로고
    • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
    • UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1998;317:713-720.
    • (1998) Br Med J , vol.317 , pp. 713-720
  • 22
    • 0023947123 scopus 로고
    • Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study
    • Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G: Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA 1988;259:1976-1982.
    • (1988) JAMA , vol.259 , pp. 1976-1982
    • Wikstrand, J.1    Warnold, I.2    Olsson, G.3    Tuomilehto, J.4    Elmfeldt, D.5    Berglund, G.6
  • 25
    • 0026512315 scopus 로고
    • Medical Research Council trial of treatment of hypertension in older adults: Principal results
    • MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
    • (1992) Br Med J , vol.304 , pp. 405-412


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.